Crossmark

Optimization of vitamin K antagonist treatment: Near patient monitoring versus standard of care a parallel group clinical trial in older patients with atrial fibrillation

Crossref DOI link: https://doi.org/10.1007/s00228-025-03878-8

Published Online: 2025-07-12

Published Print: 2025-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

van Elp, Margriet https://orcid.org/0009-0004-9293-9441
Beinema, Maarten https://orcid.org/0000-0001-6533-5416
Brouwers, Jacobus R. B. J. https://orcid.org/0000-0002-7547-1662
van ’t Riet, Esther

van de Leur, Sjef

Schreiber, Ildiko

Jansman, Frank G. A. https://orcid.org/0000-0003-2788-9578
License Information

Text and Data Mining valid from 2025-07-12

Version of Record valid from 2025-07-12
More Information

Article History

Received: 28 August 2024

Accepted: 4 July 2025

First Online: 12 July 2025

Declarations

:

: Approved by the independent Institutional Review Board Isala Hospital at Zwolle (The Netherlands) and complies with the Dutch Medical Ethical Trial Guidelines.

: Not applicable.

: Every participant provided their informed consent.

: The authors declare no conflicts of interest.

Document is current

Any future updates will be listed below